ArticleFrontiers in oncology2025

Characterization of ocular adverse events associated with crizotinib: real-world insights from the two global pharmacovigilance databases of FAERS and VigiBase.

Shuai Dong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.